For condition: Skin Cancer
For condition: Squamous Cell Carcinoma
Cutaneous Squamous Cell Carcinoma Study (36 Months)
Study Summary
Who Can Participate?
Adults (≥18 years old) with cutaneous squamous cell carcinoma can participate.
Inclusion Criteria
- invasive cutaneous squamous cell carcinoma (CSCC)
- have a CSCC lesion between 1 – 2 cm in diameter located on either the head, neck, hand, or shin
Note: There are additional study inclusion & exclusion criteria.
Participant Information
- Participate and receive study treatment at no cost
- Regular visits with study doctors who specialise in treating cutaneous squamous cell carcinoma (18 visits)
- Will receive either an investigative injection treatment (study drug) or a placebo
- Reimbursement for study-related expenses will be provided (as specifically defined in the consent form)
How Long Will The Study Last?
- 156 weeks
Note: This research study will use an investigational drug product that is being investigated for new indications, the safety and efficacy of which has not been fully evaluated by Regulatory Authorities.
For more information about this trial, please visit ClinicalTrials.gov
